StockWatch
·
Pharmaceuticals
AGM/EGM26 Aug 2026, 07:50 pm

Cohance Lifesciences Announces 8th AGM on Sep 17, 2026

AI Summary

Cohance Lifesciences Ltd. has issued a notice for its 8th Annual General Meeting (AGM) scheduled for Thursday, September 17, 2026, at 4:00 PM IST. The meeting will be conducted via Video Conference (VC) / Other Audio-Visual Means (OAVM). Key agenda items include the adoption of audited standalone and consolidated financial statements for the financial year 2025-26, and the re-appointment of Ms. Shweta Jalan as a Director. The integrated annual report for FY2025-26 is available on the company's website. E-voting will be open from September 14 to September 16, 2026, with a cut-off date of September 10, 2026.

Key Highlights

  • 8th AGM scheduled for September 17, 2026, via VC/OAVM.
  • Adoption of FY2025-26 standalone and consolidated financial statements.
  • Re-appointment of Director Ms. Shweta Jalan is on the agenda.
  • Integrated Annual Report for FY2025-26 is available online.
  • E-voting period: September 14-16, 2026.